Acutaas Chemicals: Riding the Chip and Green Energy Wave

Acutaas Chemicals, formerly Ami Organics, shifts from pharma APIs and specialty chemicals to semiconductors and batteries. Its core API business, at 73% of revenue (₹263 crore in Q2), drives stability and growth via contract manufacturing. This funds expansions, boosting H1 FY26 revenue 21% to ₹513 crore, EBITDA 86% to ₹146 crore (28% margin), and PAT 122% to ₹116 crore. Strong financials benefit shareholders with solid near-term returns. ​ Key value-add: Electrolyte additives like Vinylene Carbonate for batteries. First outside China, 2,000 MT capacity starts Q4 FY26, with orders secured. Expected 2.5x asset turn, 3-3.5 year payback enhances RoCE (25%) and RoE (23%), aiding compounding in EV/green energy boom. ​ Semiconductor play: India's sole maker of ultra-pure photoresist chemicals via Baba Fine Chemicals stake. New South Korea JV (75% stake) targets global markets from H2 FY27. Reduces China reliance, taps $100B+ India chip market by 2030. ​ For shareholders, growth diversifies revenue with high margins from niches, but execution delays in capex-heavy projects pose risks. Operating leverage lifts profits, yet high P/E (61x) vs industry (31x) demands delivery. Tech edge and export orders build moat, though cyclical chip demand and competition linger. ​ Acutaas offers exposure to megatrends with proven execution. Premium valuation reflects optimism, but sustained growth justifies it. Hold for long-term compounding if expansions scale; monitor capex returns.